Shenyang Xingqi Pharmaceutical Co Ltd
| Preis (2026-07-30) | 52W Hoch | 52W Tief |
| 42.12 CNY | 57,769 CNY | 35,1 CNY |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| - CNY | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 357.322.814 | - | - |
Beschreibung
(automatisch übersetzt)
Shenyang Xingqi Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of ophthalmic drugs in the People's Republic of China. The company offers myopia prevention and control medications, nutrition and corneal repair drugs, ophthalmic anti-inflammatory and anti-infective drugs, artificial tears and eye lubricants, ophthalmic non-steroidal anti-inflammatory drugs, intraocular rinsing fluids, pupil dilatant and ciliary muscle paralyzers, anti-fatigue medicines, dry eye treatment medicines, mydriatics and cycloplegia drugs, miotics and anti-glaucoma drugs, and intraoperative intraocular irrigation fluids. It also engages in technology development, technical advice, eye hospital, and research and experimental development activities. Shenyang Xingqi Pharmaceutical Co.,Ltd. was founded in 1977 and is based in Shenyang, the People’s Republic of China.
| Allgemein | Profitabilität | ||
|---|---|---|---|
| Industriesektor ? | Arzneimittel (Pharmazeutisch) | Operative Marge [%] ? | - |
| Marktkapitalisierung ? | - CNY | ROIC [%] ? | - |
| Enterprise Value ? | - CNY | ROIC/WACC ? | - |
| Bewertung | |||
| KGV [TTM] ? | - | EV/FCFF [TTM] ? | - |
| KGV [Forward] ? | - | EV/Sales [TTM] ? | - |
| KUV [TTM] ? | - | EV/EBITDA [TTM] ? | - |
| KBV [TTM] ? | - | ||
| Finanzielle Risiken und Liquidität | |||
| Künstl. Bonität ? | - | Zinsdeckungsgrad ? | - |
| Verschuldungsgrad [Buch] ? | - | Cash Ratio - L1 ? | - |
| Verschuldungsgrad [Markt] ? | - | Quick Ratio - L2 ? | - |
| Current Ratio - L3 ? | - | ||
| Dividenden und Aktienrückkäufe | |||
| Vergangene Jahresdividende ? | - CNY | Ausschüttungsquote ? | - % |
| Erwartete Jahresdividende ? | - CNY | Erwartete Dividendenrendite ? | - % |
| Netto Aktienrückkäufe [TTM] ? | - CNY | Effektive Ausschüttungsquote ? | - % |
| Dividendenauszahlung [TTM] ? | - CNY | Effektive Auszahlungsrendite ? | - % |
| Netto Gesamtauszahlung [TTM] ? | - CNY | ||
Kennzahlen
Gewinn/Verlust
Cash Flow
Dividenden & Aktienrückkäufe
Bilanz
Vergleichbare Unternehmen
| Name | Takani Score ? | Marktkapitalisierung | Industriesektor | Land/Region | KGV TTM | Forward KGV ? | |
|---|---|---|---|---|---|---|---|
 | Winner Medical Co Ltd | 29,5 | 2.522.870.799,053 USD | Gesundheitsprodukte | China | 22.2 | - |
| Autek China Inc | 57,09 | 1.445.319.961,702 USD | Gesundheitsprodukte | China | 21.02 | - | |
| Shanghai Tofflon Science Tech | 27,7 | 1.368.664.862,208 USD | Gesundheitsprodukte | China | 44.81 | 22.68 | |
| Shandong Intco Medical Products Co Ltd | 19,69 | 4.346.015.093,146 USD | Gesundheitsprodukte | China | 43.21 | - | |
| Andon Health Co Ltd | 71,18 | 4.612.503.590,912 USD | Gesundheitsprodukte | China | 12.62 | 82.64 | |
| Imeik Technology Development Co | 68,22 | 4.724.033.926,349 USD | Gesundheitsprodukte | China | 27.82 | 21.28 | |
| BMC Medical Co. Ltd. A | 54,84 | 867.120.846,592 USD | Gesundheitsprodukte | China | 30.43 | - | |
| Blue Sail Medical Co Ltd | 14,3 | 849.768.757,555 USD | Gesundheitsprodukte | China | - | 69.93 | |
| Truking Technology Ltd | 31,58 | 842.841.065,114 USD | Gesundheitsprodukte | China | 15.06 | - | |
| Zhejiang Chimin Pharm Co Ltd | 9,73 | 603.384.815,13 USD | Arzneimittel (Pharmazeutisch) | China | - | - |